Search Ontology:
ChEBI
gamithromycin
- Term ID
- CHEBI:195437
- Synonyms
-
- (2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-7-propyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-7-azacyclop
- (2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-15-oxo-7-propyl-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-7-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-h
- gamithromycin
- gamithromycinum
- gamitromicina
- ML 1709460
- ML-1,709,460
- ML-1709460
- ML-460
- Zactran
- Definition
- A macrolide antibiotic with formula C40H76N2O12. It is used for the treatment of of bovine respiratory disease caused by Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle. The compound is also licensed in Europe for the treatment of footrot in sheep caused by Dichelobacter nodosus and Fusobacterium nodosus.
- References
-
- AGR:IND607929431
- CAS:145435-72-9
- Chemspider:28530824
- DrugBank:DB11416
- KEGG:D06598
- PMCID:PMC8902991
- PMID:20557439
- PMID:25241389
- PMID:25619521
- PMID:26547885
- PMID:26679821
- PMID:26964715
- PMID:27171615
- PMID:28317153
- PMID:29239016
- PMID:29943581
- PMID:30928271
- PMID:31680940
- PMID:31778852
- PMID:31872885
- PMID:32059238
- PMID:32138735
- PMID:32327223
- PMID:33058489
- PMID:33072002
- PMID:33735805
- PMID:34883297
- PMID:35033769
- PMID:35170771
- PMID:35753190
- PMID:35898553
- PMID:36097302
- PMID:37270939
- PMID:37347336
- VSDB:1934
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from gamithromycin
Phenotype where environments contain gamithromycin
Phenotype modified by environments containing gamithromycin
Human Disease Model